Lv1
45 积分 2021-12-09 加入
RETRACTED ARTICLE: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey
3天前
已完结
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease
2年前
已完结
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
2年前
已完结
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
2年前
已完结
Is there a role for a maintenance rituximab in indolent lymphoproliferative diseases other than follicular lymphoma?
2年前
已完结
Therapeutic options for relapsed/refractory mantle cell lymphoma
2年前
已完结
Lineage switch in acute leukemia
3年前
已完结
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)
3年前
已完结
CD56brightnatural killer (NK) cells: an important NK cell subset
3年前
已完结
Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin
3年前
已完结
皖公网安备34019202002308
